Categories AlphaGraphs, Earnings, Health Care
Earnings: Trxade Health (MEDS) reports 16% rise in FY22 revenue; loss narrows
Trxade Health, Inc. (NASDAQ: MEDS), a leading health service IT company, reported a double-digit increase in revenues for fiscal 2022. The company’s full-year net loss narrowed from the prior year.
Revenues increased 16% from last year to $11.45 million. As a result, the net loss attributable to Trxade Health narrowed to $3.47 million or $0.41 per share in fiscal 2022 from $5.32 million or $0.65 per share in the twelve months ended December 2021.
“I am pleased with the growth we have experienced in our Trxade platform. We continue to achieve key milestones in our internal roadmap with a focus on innovation and development through our various complementary growth opportunities,” said Trxade’s CEO Suren Ajjarapu.
Trxade’s stock has gained about 52% since the beginning of the year. The shares closed Monday’s regular trading session sharply higher.
Prior Performance
Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!
Most Popular
After a positive year, what 2025 holds for IBM?
International Business Machines Corporation (NYSE: IBM) has delivered impressive financial performance in 2024 by focusing on higher-value businesses. The company’s software business experienced stable growth, offsetting softness in its consulting
What to expect when Delta Air Lines (DAL) reports Q4 2024 earnings
Shares of Delta Air Lines (NYSE: DAL) fell 2% on Friday. The stock has gained 17% over the past three months. The airline is scheduled to report its earnings results
Walgreens Boots Alliance expected to report mixed Q1 2025 results
For Walgreens Boots Alliance, Inc. (NASDAQ: WBA), 2024 was a challenging year as it lost market share to competitors and closed several stores amid persistent operational headwinds. It is expected
